170 related articles for article (PubMed ID: 18253741)
21. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
[TBL] [Abstract][Full Text] [Related]
22. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
23. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
24. [Markers of epidermal proliferation in middle ear cholesteatoma].
Hassmann-Poznańska E; Skotnicka B; Dziecioł J
Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
[TBL] [Abstract][Full Text] [Related]
25. Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue.
Barbara M; Raffa S; Murè C; Manni V; Ronchetti F; Monini S; Torrisi MR
Acta Otolaryngol; 2008 Apr; 128(4):360-4. PubMed ID: 18368565
[TBL] [Abstract][Full Text] [Related]
26. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
Schmidt M; Grünsfelder P; Hoppe F
Eur Arch Otorhinolaryngol; 2000; 257(8):425-9. PubMed ID: 11073191
[TBL] [Abstract][Full Text] [Related]
27. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
28. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
29. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
[TBL] [Abstract][Full Text] [Related]
30. Galectin-7 as a marker of cholesteatoma residue and its detection during surgery by an immunofluorescent method--a preliminary study.
Takagi D; Hato N; Okada M; Hakuba N; Gyo K; Shigemoto K; Toda T; Ogasawara M; Kameda K
Otol Neurotol; 2012 Apr; 33(3):396-9. PubMed ID: 22377647
[TBL] [Abstract][Full Text] [Related]
31. Canine aural cholesteatoma: a histological and immunohistochemical study.
Banco B; Grieco V; Di Giancamillo M; Greci V; Travetti O; Martino P; Mortellaro CM; Giudice C
Vet J; 2014 Jun; 200(3):440-5. PubMed ID: 24775276
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study during healing of free palatal mucosa grafts on plastic-embedded samples.
Lauer G; Wiedmann-Al-Ahmad M; Otten JE; Hübner U
J Oral Pathol Med; 2001 Feb; 30(2):104-12. PubMed ID: 11168855
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical investigations on external auditory canal cholesteatomas.
Adamczyk M; Sudhoff H; Jahnke K
Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
[TBL] [Abstract][Full Text] [Related]
34. Binding of indocyanine green in polycaprolactone fibers using blend electrospinning for in vivo laser-assisted vascular anastomosis.
Schönfeld A; Kabra ZM; Constantinescu M; Bosshardt D; Stoffel MH; Peters K; Frenz M
Lasers Surg Med; 2017 Dec; 49(10):928-939. PubMed ID: 28699660
[TBL] [Abstract][Full Text] [Related]
35. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
Schmidt M; Schler G; Gruensfelder P; Hoppe F
Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
[TBL] [Abstract][Full Text] [Related]
36. Histopathological evaluation and long-term results of soft tissue preservation technique in cholesteatoma surgery.
Hiraumi H; Kanemaru SI; Miura M; Yamamoto N; Sakamoto T; Ito J
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):711-714. PubMed ID: 27699471
[TBL] [Abstract][Full Text] [Related]
37. Curved adjustable fiberoptic laser for endoscopic cholesteatoma surgery.
Yau AY; Mahboubi H; Maducdoc M; Ghavami Y; Djalilian HR
Otol Neurotol; 2015 Jan; 36(1):61-4. PubMed ID: 25279936
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
39. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.
Nagai T; Suganuma T; Ide S; Shimoda H; Kato S
Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):361-4. PubMed ID: 16328407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
